Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments
Gliomas are one of the most lethal types of cancers accounting for ∼80% of all central nervous system (CNS) primary malignancies. Among gliomas, glioblastomas (GBM) are the most aggressive, characterized by a median patient survival of fewer than 15 months. Recent molecular characterization studies...
Κύριοι συγγραφείς: | Mahmoud S. Alghamri, Brandon L. McClellan, Carson S. Hartlage, Santiago Haase, Syed Mohd Faisal, Rohit Thalla, Ali Dabaja, Kaushik Banerjee, Stephen V. Carney, Anzar A. Mujeeb, Michael R. Olin, James J. Moon, Anna Schwendeman, Pedro R. Lowenstein, Maria G. Castro |
---|---|
Μορφή: | Άρθρο |
Γλώσσα: | English |
Έκδοση: |
Frontiers Media S.A.
2021-05-01
|
Σειρά: | Frontiers in Pharmacology |
Θέματα: | |
Διαθέσιμο Online: | https://www.frontiersin.org/articles/10.3389/fphar.2021.680021/full |
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Murine brain tumor microenvironment immunophenotyping using mass cytometry
ανά: Brandon L. McClellan, κ.ά.
Έκδοση: (2022-06-01) -
Impact of epigenetic reprogramming on antitumor immune responses in glioma
ανά: Brandon L. McClellan, κ.ά.
Έκδοση: (2023-01-01) -
Genetic Alterations in Gliomas Remodel the Tumor Immune Microenvironment and Impact Immune-Mediated Therapies
ανά: Maria B. Garcia-Fabiani, κ.ά.
Έκδοση: (2021-06-01) -
Development of immunotherapy for high-grade gliomas: Overcoming the immunosuppressive tumor microenvironment
ανά: Andrea Franson, κ.ά.
Έκδοση: (2022-09-01) -
H3.3-G34 mutations impair DNA repair and promote cGAS/STING-mediated immune responses in pediatric high-grade glioma models
ανά: Santiago Haase, κ.ά.
Έκδοση: (2022-11-01)